Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease
- 29 February 2004
- journal article
- review article
- Published by Elsevier BV in Clinics in Liver Disease
- Vol. 8 (1), 67-81
- https://doi.org/10.1016/s1089-3261(03)00135-1
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Ursodeoxycholic acid aggravates bile infarcts in bile duct–ligated and Mdr2 knockout mice via disruption of cholangiolesGastroenterology, 2002
- Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisitedJournal of Hepatology, 2002
- Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosisDigestive and Liver Disease, 2002
- Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein geneGastroenterology, 1996
- Pharmacology of Ursodeoxycholic Acid, an Enterohepatic DrugScandinavian Journal of Gastroenterology, 1994
- Molecular aspects of membrane stabilization by ursodeoxycholateGastroenterology, 1993
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisThe New England Journal of Medicine, 1991
- Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trialGastroenterology, 1989
- IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?The Lancet, 1987
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985